Rani Therapeutics Holdings, Inc. (RANI) Ownership

$1.49

south_east
-$0.04 (-2.3%)
Day's range
$1.46
Day's range
$1.6

Rani Therapeutics Holdings, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 02/11/2025 709,828 $972,465   0.00% 2.46%
NAN FUNG GROUP HOLDINGS LTD 02/13/2025 493,584 $676,210   0.00% 1.71%
ALPHABET INC. 02/07/2025 448,492 $614,434   0.00% 1.56%
UNITED SERVICES AUTOMOBILE ASSOCIATION 02/11/2025 302,743 $414,758   0.00% 1.05%
TWO SIGMA INVESTMENTS, LP 02/14/2025 291,381 $399,192   100.00% 1.01%
TAKEDA PHARMACEUTICAL CO LTD 02/12/2025 203,190 $278,370   0.00% 0.70%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 171,573 $235,112   -0.40% 0.60%
KESTRA PRIVATE WEALTH SERVICES, LLC 01/28/2025 119,620 $163,879   100.00% 0.41%
TWO SIGMA ADVISERS, LP 02/14/2025 110,163 $150,923   100.00% 0.38%
BLACKROCK FUNDING, INC. /DE 02/07/2025 63,583 $87,109   0.00% 0.22%
LASRY MARC 02/14/2025 62,887 $86,155   0.00% 0.22%
STATE STREET CORP 02/14/2025 62,442 $85,546   48.52% 0.22%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 56,500 $77,405   -20.98% 0.20%
MOTCO 02/05/2025 48,129 $65,937   0.00% 0.17%
INSIGNEO ADVISORY SERVICES, LLC 02/13/2025 47,500 $65,075   100.00% 0.16%
VIRTU FINANCIAL LLC 02/11/2025 45,404 $62,000   100.00% 0.16%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 40,700 $55,759   100.00% 0.14%
KING LUTHER CAPITAL MANAGEMENT CORP 02/07/2025 33,000 $45,210   -59.32% 0.11%
BROWN ADVISORY INC 02/14/2025 32,911 $45,088   0.00% 0.11%
PRIME CAPITAL INVESTMENT ADVISORS, LLC 02/12/2025 27,208 $37,275   136.90% 0.09%
UBS GROUP AG 02/14/2025 23,525 $32,230   49.75% 0.08%
LAFAYETTE INVESTMENTS, INC. 02/13/2025 19,893 $27,254   0.00% 0.07%
GROUND SWELL CAPITAL, LLC 02/14/2025 17,153 $23,500   100.00% 0.06%
STIFEL FINANCIAL CORP 02/13/2025 14,684 $20,117   -94.56% 0.05%
XTX TOPCO LTD 02/13/2025 12,890 $17,659   100.00% 0.04%
CHOREO, LLC 01/27/2025 11,813 $16,404   100.00% 0.04%
SQUAREPOINT OPS LLC 02/14/2025 10,863 $14,882   100.00% 0.04%
COMMONWEALTH EQUITY SERVICES, LLC 02/10/2025 10,409 $14,000   100.00% 0.04%
CERITY PARTNERS LLC 02/13/2025 10,000 $13,700   0.00% 0.03%
ISLAY CAPITAL MANAGEMENT, LLC 02/13/2025 9,611 $13,167   0.00% 0.03%
02/06/2025 7,099 $9,726   100.00% 0.02%
ALLWORTH FINANCIAL LP 01/30/2025 3,119 $4,648   0.00% 0.01%
01/23/2025 2,170 $2,973   100.00% 0.01%
PNC FINANCIAL SERVICES GROUP, INC. 02/07/2025 2,000 $2,740   0.00% 0.01%
ALPHAMARK ADVISORS, LLC 01/21/2025 500 $1,000   100.00% 0.00%
01/29/2025 100 $137   100.00% 0.00%
JPMORGAN CHASE & CO 02/12/2025 71 $97   0.00% 0.00%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 0 $0   -100.00% 0.00%
MILLENNIUM MANAGEMENT LLC 02/14/2025 0 $0   -100.00% 0.00%
SIMPLEX TRADING, LLC 02/11/2025 0 $0   -100.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 02/13/2025 0 $0   -100.00% 0.00%
ARMISTICE CAPITAL, LLC 02/14/2025 0 $0   -100.00% 0.00%

Rani Therapeutics Holdings, Inc. institutional Ownership - FAQ's

During the previous two years, 45 institutional investors and hedge funds held shares of Rani Therapeutics Holdings, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 709,828

Nan Fung Group Holdings Ltd: 493,584

Alphabet Inc.: 448,492

UNITED SERVICES AUTOMOBILE ASSOCIATION: 302,743

TWO SIGMA INVESTMENTS, LP: 291,381

TAKEDA PHARMACEUTICAL CO LTD: 203,190

13.24% of Rani Therapeutics Holdings, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 3.82 M shares in the last 24 months. This purchase volume represents approximately $5.69 M in transactions.